Qube Research & Technologies (QRT)’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-16,763
| Closed | -$93.9K | – | 3790 |
|
|
2024
Q2 | $93.9K | Buy |
16,763
+13,212
| +372% | +$74K | ﹤0.01% | 2257 |
|
|
2024
Q1 | $18.6K | Sell |
3,551
-12,296
| -78% | -$64.4K | ﹤0.01% | 3195 |
|
|
2023
Q4 | $82.9K | Sell |
15,847
-1,937
| -11% | -$10.1K | ﹤0.01% | 2753 |
|
|
2023
Q3 | $280K | Sell |
17,784
-14,592
| -45% | -$230K | ﹤0.01% | 1884 |
|
|
2023
Q2 | $629K | Buy |
32,376
+3,667
| +13% | +$71.3K | ﹤0.01% | 1384 |
|
|
2023
Q1 | $814K | Sell |
28,709
-3,722
| -11% | -$106K | ﹤0.01% | 1312 |
|
|
2022
Q4 | $948K | Sell |
32,431
-5,899
| -15% | -$172K | 0.01% | 1178 |
|
|
2022
Q3 | $1.01M | Buy |
+38,330
| New | +$1.01M | 0.01% | 1148 |
|
|
2022
Q2 | – | Sell |
-7,158
| Closed | -$354K | – | 3233 |
|
|
2022
Q1 | $354K | Sell |
7,158
-2,635
| -27% | -$130K | ﹤0.01% | 1683 |
|
|
2021
Q4 | $499K | Buy |
+9,793
| New | +$499K | ﹤0.01% | 1570 |
|
|
2021
Q2 | – | Sell |
-6,729
| Closed | -$281K | – | 2893 |
|
|
2021
Q1 | $281K | Buy |
6,729
+1,209
| +22% | +$50.5K | ﹤0.01% | 1490 |
|
|
2020
Q4 | $257K | Buy |
+5,520
| New | +$257K | ﹤0.01% | 1414 |
|